Skip to main content
PMC home page
British Journal of Preventive & Social Medicine logoLink to British Journal of Preventive & Social Medicine
. 1975 Mar;29(1):1–17. doi: 10.1136/jech.29.1.1

The contribution of virology to contemporary medicine.

C Stuart-Harris
PMCID: PMC478880  PMID: 1093599

Full text

PDF
4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahström L., Dohlwitz A., Strander H., Carlström G., Cantell K. Letter: Interferon in acute leukaemia in children. Lancet. 1974 Feb 2;1(7849):166–167. doi: 10.1016/s0140-6736(74)92458-1. [DOI] [PubMed] [Google Scholar]
  2. BLUMBERG B. S., ALTER H. J., VISNICH S. A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA. 1965 Feb 15;191:541–546. doi: 10.1001/jama.1965.03080070025007. [DOI] [PubMed] [Google Scholar]
  3. Bauer D. J., St Vincent L., Kempe C. H., Young P. A., Downie A. W. Prophylaxis of smallpox with methisazone. Am J Epidemiol. 1969 Aug;90(2):130–145. doi: 10.1093/oxfordjournals.aje.a121057. [DOI] [PubMed] [Google Scholar]
  4. Beare A. S., Hall T. S., Tyrrell D. A. Protection of volunteers against challenge with A-Hong Kong-68 influenza virus by a new adamantane compound. Lancet. 1972 May 13;1(7759):1039–1040. doi: 10.1016/s0140-6736(72)91220-2. [DOI] [PubMed] [Google Scholar]
  5. Brotman B., Prince A. M., Godfrey H. R. Role of arthropods in transmission of hepatitis-B virus in the tropics. Lancet. 1973 Jun 9;1(7815):1305–1308. doi: 10.1016/s0140-6736(73)91311-1. [DOI] [PubMed] [Google Scholar]
  6. Buckley T. F., MacCallum F. O. Herpes simplex virus encephalitis treated with idoxuridine. Br Med J. 1967 May 13;2(5549):419–420. doi: 10.1136/bmj.2.5549.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Campbell J. B., Kaplan M. M., Koprowski H., Kuwert E., Sokol F., Wiktor T. J. Present trends and the future in rabies research. Bull World Health Organ. 1968;38(3):373–381. [PMC free article] [PubMed] [Google Scholar]
  8. Chow A. W., Roland A., Fiala M., Hryniuk W., Weil M. L., Geme J. S., Jr, Guze L. B. Cytosine arabinoside therapy for herpes simplex encephalitis--clinical experience with six patients. Antimicrob Agents Chemother. 1973 Mar;3(3):412–417. doi: 10.1128/aac.3.3.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dawkins A. T., Jr, Gallager L. R., Togo Y., Hornick R. B., Harris B. A. Studies on induced influenza in man. II. Double-blind study designed to assess the prophylactic efficacy of an analogue of amantadine hydrochloride. JAMA. 1968 Mar 25;203(13):1095–1099. doi: 10.1001/jama.203.13.1095. [DOI] [PubMed] [Google Scholar]
  10. Dennis D. T., Doberstyn E. B., Awoke S., Royer G. L., Jr, Renis H. E. Failure of cytosine arabinoside in treating smallpox. A double-blind study. Lancet. 1974 Aug 17;2(7877):377–379. doi: 10.1016/s0140-6736(74)91759-0. [DOI] [PubMed] [Google Scholar]
  11. ENDERS J. F., KATZ S. L., MILOVANOVIC M. V., HOLLOWAY A. Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination. N Engl J Med. 1960 Jul 28;263:153–159. doi: 10.1056/NEJM196007282630401. [DOI] [PubMed] [Google Scholar]
  12. ENDERS J. F., PEEBLES T. C. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med. 1954 Jun;86(2):277–286. doi: 10.3181/00379727-86-21073. [DOI] [PubMed] [Google Scholar]
  13. Fazekas de St Groth New criteria for the selection of influenza vaccine strains. Bull World Health Organ. 1969;41(3):651–657. [PMC free article] [PubMed] [Google Scholar]
  14. GIBBONS J. L., MILLER H. G., STANTON J. B. Para-infectious encephalomyelitis and related syndromes; a critical review of the neurological complications of certain specific fevers. Q J Med. 1956 Oct;25(100):427–505. [PubMed] [Google Scholar]
  15. GRUNERT R. R., MCGAHEN J. W., DAVIES W. L. THE IN VIVO ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE). I. PROPHYLACTIC AND THERAPEUTIC ACTIVITY AGAINST INFLUENZA VIRUSES. Virology. 1965 Jun;26:262–269. doi: 10.1016/0042-6822(65)90273-4. [DOI] [PubMed] [Google Scholar]
  16. Galbraith A. W., Oxford J. S., Schild G. C., Watson G. I. Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study. Lancet. 1969 Nov 15;2(7629):1026–1028. doi: 10.1016/s0140-6736(69)90639-4. [DOI] [PubMed] [Google Scholar]
  17. Gale E. F. Perspectives in chemotherapy. Br Med J. 1973 Oct 6;4(5883):33–38. doi: 10.1136/bmj.4.5883.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Grossberg S. E. The interferons and their inducers: molecular and therapeutic considerations. 3. N Engl J Med. 1972 Jul 20;287(3):122–128. doi: 10.1056/NEJM197207202870305. [DOI] [PubMed] [Google Scholar]
  19. Hannoun C. Un nouveau pas dans la vaccination antigrippale. I. Unvaccin prospectif contre la grippe. Nouv Presse Med. 1973 May 5;2(18):1199–1202. [PubMed] [Google Scholar]
  20. Heiner G. G., Fatima N., Russell P. K., Haase A. T., Ahmad N., Mohammed N., Thomas D. B., Mack T. M., Khan M. M., Knatterud G. L. Field trials of methisazone as a prophylactic agent against smallpox. Am J Epidemiol. 1971 Nov;94(5):435–449. doi: 10.1093/oxfordjournals.aje.a121340. [DOI] [PubMed] [Google Scholar]
  21. Henderson D. A. Epidemiology in the global eradication of smallpox. Int J Epidemiol. 1972 Spring;1(1):25–30. doi: 10.1093/ije/1.1.25. [DOI] [PubMed] [Google Scholar]
  22. Heyworth B. Letter: Pathogenesis of measles. Br Med J. 1973 Sep 29;3(5882):693–693. doi: 10.1136/bmj.3.5882.693-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hill D. A., Baron S., Chanock R. M. The effect of an interferon inducer on influenza virus. Bull World Health Organ. 1969;41(3):689–693. [PMC free article] [PubMed] [Google Scholar]
  24. Hill D. A., Baron S., Perkins J. C., Worthington M., Van Kirk J. E., Mills J., Kapikian A. Z., Chanock R. M. Evaluation of an interferon inducer in viral respiratory disease. JAMA. 1972 Feb 28;219(9):1179–1184. [PubMed] [Google Scholar]
  25. Hossain M. S., Foerster J., Hryniuk W., Israels L. G., Chowdhury A. S., Biswas M. K. Treatment of smallpox with cytosine arabinoside. Lancet. 1972 Dec 9;2(7789):1230–1232. doi: 10.1016/s0140-6736(72)92276-3. [DOI] [PubMed] [Google Scholar]
  26. ISAACS A., COX R. A., ROTEM Z. Foreign nucleic acids as the stimulus to make interferon. Lancet. 1963 Jul 20;2(7299):113–116. doi: 10.1016/s0140-6736(63)92585-6. [DOI] [PubMed] [Google Scholar]
  27. ISAACS A., LINDENMANN J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci. 1957 Sep 12;147(927):258–267. doi: 10.1098/rspb.1957.0048. [DOI] [PubMed] [Google Scholar]
  28. Jeffries D. J., James W. H., Jefferiss F. J., MacLeod K. G., Willcox R. R. Australia (hepatitis-associated) antigen in patients attending a venereal disease clinic. Br Med J. 1973 May 26;2(5864):455–456. doi: 10.1136/bmj.2.5864.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kato N., Eggers H. J. Inhibition of uncoating of fowl plague virus by l-adamantanamine hydrochloride. Virology. 1969 Apr;37(4):632–641. doi: 10.1016/0042-6822(69)90281-5. [DOI] [PubMed] [Google Scholar]
  30. Kolbourne E. D. Recombination of influenza A viruses of human and animal origin. Science. 1968 Apr 5;160(3823):74–76. doi: 10.1126/science.160.3823.74. [DOI] [PubMed] [Google Scholar]
  31. Krugman S., Giles J. P. Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention. N Engl J Med. 1973 Apr 12;288(15):755–760. doi: 10.1056/NEJM197304122881503. [DOI] [PubMed] [Google Scholar]
  32. LWOFF A. The concept of virus. J Gen Microbiol. 1957 Oct;17(2):239–253. doi: 10.1099/00221287-17-2-239. [DOI] [PubMed] [Google Scholar]
  33. Laver W. G., Webster R. G. Studies on the origin of pandemic influenza. 3. Evidence implicating duck and equine influenza viruses as possible progenitors of the Hong Kong strain of human influenza. Virology. 1973 Feb;51(2):383–391. doi: 10.1016/0042-6822(73)90437-6. [DOI] [PubMed] [Google Scholar]
  34. Levine M. M. Live-virus vaccines in pregnancy. Risks and recommendations. Lancet. 1974 Jul 6;2(7871):34–38. doi: 10.1016/s0140-6736(74)91363-4. [DOI] [PubMed] [Google Scholar]
  35. MILLER D. L. FREQUENCY OF COMPLICATIONS OF MEASLES, 1963. REPORT ON A NATIONAL INQUIRY BY THE PUBLIC HEALTH LABORATORY SERVICE IN COLLABORATION WITH THE SOCIETY OF MEDICAL OFFICERS OF HEALTH. Br Med J. 1964 Jul 11;2(5401):75–78. doi: 10.1136/bmj.2.5401.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Merigan T. C., Reed S. E., Hall T. S., Tyrrell D. A. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973 Mar 17;1(7803):563–567. doi: 10.1016/s0140-6736(73)90714-9. [DOI] [PubMed] [Google Scholar]
  37. Miller D. L., Reid D., Diamond J. R. Poliomyelitis surveillance in England and Wales, 1965-8. Public Health. 1970 Sep;84(6):265–285. doi: 10.1016/s0033-3506(70)80065-8. [DOI] [PubMed] [Google Scholar]
  38. Morley D. Severe measles in the tropics. I. Br Med J. 1969 Feb 1;1(5639):297–contd. doi: 10.1136/bmj.1.5639.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Moss B., Rosenblum E. N., Grimley P. M. Assembly of virus particles during mixed infection with wild-type vaccinia and a rifampicin-resistant mutant. Virology. 1971 Jul;45(1):135–148. doi: 10.1016/0042-6822(71)90120-6. [DOI] [PubMed] [Google Scholar]
  40. Moss B., Rosenblum E. N., Katz E., Grimley P. M. Rifampicin: a specific inhibitor of vaccinia virus assembly. Nature. 1969 Dec 27;224(5226):1280–1284. doi: 10.1038/2241280a0. [DOI] [PubMed] [Google Scholar]
  41. Nafta I., TTurcanu A. G., Braun I., Companetz W., Simionescu A., Birţ E., Florea V. Administration of amantadine for the prevention of Hong Kong influenza. Bull World Health Organ. 1970;42(3):423–427. [PMC free article] [PubMed] [Google Scholar]
  42. Nolan D. C., Lauter C. B., Lerner A. M. Idoxuridine in herpes simplex virus (type 1) encephalitis. Experience with 29 cases in Michigan, 1966 to 1971. Ann Intern Med. 1973 Feb;78(2):243–246. doi: 10.7326/0003-4819-78-2-243. [DOI] [PubMed] [Google Scholar]
  43. Nonoyama M., Pagano J. S. Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature. 1973 Mar 2;242(5392):44–47. doi: 10.1038/242044a0. [DOI] [PubMed] [Google Scholar]
  44. Oker-Blom N., Hovi T., Leinikki P., Palosuo T., Pettersson R., Suni J. Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: a controlled field trial. Br Med J. 1970 Sep 19;3(5724):676–678. doi: 10.1136/bmj.3.5724.676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Oxford J. S. An inhibitor of the particle-associated RNA-dependent RNA polymerase of influenza A and B viruses. J Gen Virol. 1973 Jan;18(1):11–19. doi: 10.1099/0022-1317-18-1-11. [DOI] [PubMed] [Google Scholar]
  46. PARKMAN P. D., BUESCHER E. L., ARTENSTEIN M. S. Recovery of rubella virus from army recruits. Proc Soc Exp Biol Med. 1962 Oct;111:225–230. doi: 10.3181/00379727-111-27750. [DOI] [PubMed] [Google Scholar]
  47. Panusarn C., Stanley E. D., Dirda V., Rubenis M., Jackson G. G. Prevention of illness from rhinovirus infection by a topical interferon inducer. N Engl J Med. 1974 Jun 11;291(2):57–61. doi: 10.1056/NEJM197407112910201. [DOI] [PubMed] [Google Scholar]
  48. Paul J. R. PRESIDENT'S ADDRESS CLINICAL EPIDEMIOLOGY. J Clin Invest. 1938 Sep;17(5):539–541. doi: 10.1172/JCI100978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Prusoff W. H., Goz B. Potential mechanisms of action of antiviral agents. Fed Proc. 1973 Jun;32(6):1679–1687. [PubMed] [Google Scholar]
  50. Reid D., Bell E. J., Grist N. R., Wilson T. S. Poliomyelitis: A gap in immunity? Lancet. 1973 Oct 20;2(7834):899–900. doi: 10.1016/s0140-6736(73)92022-9. [DOI] [PubMed] [Google Scholar]
  51. SCHWARZ A. J. IMMUNIZATION AGAINST MEASLES: DEVELOPMENT AND EVALUATION OF A HIGHLY ATTENUATED LIVE MEASLES VACCINE. Ann Paediatr. 1964;202:241–252. [PubMed] [Google Scholar]
  52. STUART-HARRIS C. H. Viruses of human diseases. Br Med J. 1962 Jun 30;1(5295):1779–1788. doi: 10.1136/bmj.1.5295.1779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Skelton J., Schild G. C., Stuart-Harris C. H. Screening of children's sera for antibodies to polioviruses. Mon Bull Minist Health Public Health Lab Serv. 1966 Sep;25:191–193. [PubMed] [Google Scholar]
  54. Stanley W. M. ISOLATION OF A CRYSTALLINE PROTEIN POSSESSING THE PROPERTIES OF TOBACCO-MOSAIC VIRUS. Science. 1935 Jun 28;81(2113):644–645. doi: 10.1126/science.81.2113.644. [DOI] [PubMed] [Google Scholar]
  55. Stevens D. A., Jordan G. W., Waddell T. F., Merigan T. C. Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial. N Engl J Med. 1973 Oct 25;289(17):873–878. doi: 10.1056/NEJM197310252891701. [DOI] [PubMed] [Google Scholar]
  56. Subak-Sharpe J. H., Timbury M. C., Williams J. F. Rifampicin inhibits the growth of some mammalian viruses. Nature. 1969 Apr 26;222(5191):341–345. doi: 10.1038/222341a0. [DOI] [PubMed] [Google Scholar]
  57. Sutherland I., Fayers P. M. Effect of measles vaccination on incidence of measles in the community. Br Med J. 1971 Mar 27;1(5751):698–702. doi: 10.1136/bmj.1.5751.698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Szmuness W., Prince A. M., Goodman M., Ehrich C., Pick R., Ansari M. Hepatitis B immune serum globulin in prevention of nonparenterally transmitted hepatitis B. N Engl J Med. 1974 Mar 28;290(13):701–706. doi: 10.1056/NEJM197403282901302. [DOI] [PubMed] [Google Scholar]
  59. TYLER H. R. Neurological complications of rubeola (measles). Medicine (Baltimore) 1957 May;36(2):147–167. doi: 10.1097/00005792-195705000-00001. [DOI] [PubMed] [Google Scholar]
  60. Togo Y., Hornick R. B., Dawkins A. T., Jr Studies on induced influenza in man. I. Double-blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against a2/Rockville/1/65 strain. JAMA. 1968 Mar 25;203(13):1089–1094. doi: 10.1001/jama.203.13.1089. [DOI] [PubMed] [Google Scholar]
  61. Togo Y., Hornick R. B., Felitti V. J., Kaufman M. L., Dawkins A. T., Jr, Kilpe V. E., Claghorn J. L. Evaluation of therapeutic efficacy of amantadine in patients with naturally occurring A2 influenza. JAMA. 1970 Feb 16;211(7):1149–1156. [PubMed] [Google Scholar]

Articles from British journal of preventive & social medicine are provided here courtesy of BMJ Publishing Group

RESOURCES